[1] Bauer SL, Wall GC, Skoglund KJ, et al.Lack of cross-reactivity to meropenem in a patient with an allergy to imipenem-cilastatin[J]. J Allergy Clin Immunol, 2004(113): 173-175. [2] Romano A, Gaeta F, Poves MFA, et al.Cross-Reactivity among Beta-Lactams[J]. Current Allergy and Asthma Reports, 2016, 16(3): 24. [3] Yang H, Wei J, Wang JY, et al.Study on evaluation methods of adverse drug reaction/event report[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2009, 6(10): 581-584. [4] Naranjo CA, Busto U, Sellers EM, et al.A method for estimating the probability of adverse drug reactions[J]. Clin Pharmacol Ther, 1981, 30(2): 239-245. [5] Kula B, Djordjevic G, Robinson JL.A systematic review: can one prescribe carbapenems to patients with ige-mediated allergy to penicillins or cephalosporins?[J]. Clinical Infectious Diseases, 2014, 59(8): 1113-1122. [6] Picard M, Robitaille G, Karam F, et al.Cross-reactivity to cephalosporins and carbapenems in penicillin-allergic patients: two systematic reviews and meta-analyses[J]. J Allergy Clin Immunol Pract, 2019, 7(8): 2722-2738. [7] Romano A, Gaeta F, Valluzzi RL, et al.IgE-mediated hyperse-nsitivity to cephalosporins: Cross-reactivity and tolerability of penicillins, monobactams, and carbapenems[J]. J Allergy Clin Immunol, 2010, 126(5): 994-999. [8] Lakhal K, Lortat-Jacob B, Neukirch C, et al.Safe use of meropenem in a patient with a possible nonimmediate allergy to imipenem[J]. Pharmacotherapy, 2007, 27(9): 1334-1338. [9] Lee Y, Bradley N.Overview and insights into carbapenem allergy[J].Pharmacy (Basel), 2019, 7(3): 110. [10] Robinson JL, Hameed T, Carr S.Practical aspects of choosing an antibiotic for patients with a reported allergy to an antibiotic[J]. Clinical Infectious Diseases, 2002, 35(1): 26-31. [11] Noguerado-Mellado B, Pinto Fernández C, Pineda-Pineda R, et al.Cross-reactivity between carbapenems: two case reports[J]. The Journal of Allergy and Clinical Immunology: In Practice, 2014, 2(6): 816-817. [12] Gil-Serrano J, Cardona V, Luengo O, et al.Anaphylactic shock to meropenem with ertapenem tolerance: a case report[J]. J Allergy Clin Immunol Pract, 2019, 7(6): 2057-2058. [13] Expert committee on clinical use of antimicrobials and evaluation of antimicrobal resistance. Penicillin skin test expert consensus[J]. Natl Med J China(中华医学杂志), 2017, 97(40): 3143-3146. [14] Zhejiang Pharmaceutical Administration Quality Control Center, Zhejiang Society of Microbiology and Immunology, Zhejiang Nursing Quality Control Center. Guidance on skin allergy test of cephalosporin antibiotics in Zhejiang province[S]. 2018. . Guidance on skin allergy test of cephalosporin antibiotics in Zhejiang province[S]. 2018. http://t5.1il.cn/TZGG/ShowContent_11454.html. [15] Chongqing Pharmaceutical Administration Quality Control Center. Consensus on skin allergy test of cephalosporin antibacterial agents in Chongqing[S]. 2018[2020-01-01]. . Consensus on skin allergy test of cephalosporin antibacterial agents in Chongqing[S]. 2018[2020-01-01]. http://www.clinphar.cn/thread-417911-1-1.html. [16] Morgado F, Santiago L, Gonçalo M.Safe use of imipenem after delayed hypersensitivity to meropenem-Value of patch tests[J]. Contact Dermatitis, 2020, 82(3): 190-191. |